You are preforming a pre-op review of a surgical patient. Th…
You are preforming a pre-op review of a surgical patient. The patient is taking sacubitril/valsartan (Entresto®) for heart failure. What class of drugs should not be administered within 36 hours of sacubitril/valsartan to avoid the risk of angioedema and/or hyperkalemia?